[
  {
    "ts": null,
    "headline": "Incyte Announces FDA Approval of Monjuvi速 (tafasitamab-cxix) in Combination with Rituximab and Lenalidomide for Patients with Relapsed or Refractory Follicular Lymphoma",
    "summary": "WILMINGTON, Del., June 18, 2025--Incyte (Nasdaq:INCY) today announced that the U.S. Food and Drug Administration (FDA) has approved Monjuvi速 (tafasitamab-cxix), a humanized Fc-modified cytolytic CD19-targeting monoclonal antibody, in combination with rituximab and lenalidomide for the treatment of adult patients with relapsed or refractory follicular lymphoma (FL).",
    "url": "https://finnhub.io/api/news?id=7975306fa5525af3b555399b031ed3be9fa85b93303bf3379eb01e86320faaea",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750275540,
      "headline": "Incyte Announces FDA Approval of Monjuvi速 (tafasitamab-cxix) in Combination with Rituximab and Lenalidomide for Patients with Relapsed or Refractory Follicular Lymphoma",
      "id": 135379305,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "INCY",
      "source": "Yahoo",
      "summary": "WILMINGTON, Del., June 18, 2025--Incyte (Nasdaq:INCY) today announced that the U.S. Food and Drug Administration (FDA) has approved Monjuvi速 (tafasitamab-cxix), a humanized Fc-modified cytolytic CD19-targeting monoclonal antibody, in combination with rituximab and lenalidomide for the treatment of adult patients with relapsed or refractory follicular lymphoma (FL).",
      "url": "https://finnhub.io/api/news?id=7975306fa5525af3b555399b031ed3be9fa85b93303bf3379eb01e86320faaea"
    }
  },
  {
    "ts": null,
    "headline": "Incyte Lymphoma Treatment Gets FDA Approval",
    "summary": "By Kelly Cloonan Incyte said it received approval from the Food and Drug Administration for monjuvi, in combination with rituximab and lenalidomide, as a treatment for follicular lymphoma. ...",
    "url": "https://finnhub.io/api/news?id=1f61c97b4465e56e92d58708bc85532cd83b6a354b1354cb3f5e1d1129fc1d01",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1750264088,
      "headline": "Incyte Lymphoma Treatment Gets FDA Approval",
      "id": 135373839,
      "image": "",
      "related": "INCY",
      "source": "Finnhub",
      "summary": "By Kelly Cloonan Incyte said it received approval from the Food and Drug Administration for monjuvi, in combination with rituximab and lenalidomide, as a treatment for follicular lymphoma. ...",
      "url": "https://finnhub.io/api/news?id=1f61c97b4465e56e92d58708bc85532cd83b6a354b1354cb3f5e1d1129fc1d01"
    }
  }
]